loading
Vtv Therapeutics Inc stock is traded at $14.42, with a volume of 9,057. It is up +3.00% in the last 24 hours and down -1.17% over the past month. vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
See More
Previous Close:
$14.00
Open:
$13.9
24h Volume:
9,057
Relative Volume:
0.37
Market Cap:
$34.06M
Revenue:
$5.02M
Net Income/Loss:
$-20.25M
P/E Ratio:
-60.08
EPS:
-0.24
Net Cash Flow:
$-19.08M
1W Performance:
+3.30%
1M Performance:
-1.17%
6M Performance:
-38.98%
1Y Performance:
+3,595%
1-Day Range:
Value
$13.90
$14.50
1-Week Range:
Value
$13.50
$15.14
52-Week Range:
Value
$0.35
$30.99

Vtv Therapeutics Inc Stock (VTVT) Company Profile

Name
Name
Vtv Therapeutics Inc
Name
Phone
336-841-0300
Name
Address
3980 PREMIER DR, HIGH POINT, NC
Name
Employee
16
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
VTVT's Discussions on Twitter

Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades

Date Action Analyst Rating Change
May-30-19 Initiated H.C. Wainwright Buy
Apr-10-18 Downgrade Stifel Buy → Hold
Mar-08-18 Initiated ROTH Capital Buy
Feb-08-18 Initiated Northland Capital Outperform
Sep-26-16 Initiated H.C. Wainwright Buy
Sep-04-15 Initiated Canaccord Genuity Buy
Aug-24-15 Initiated Piper Jaffray Overweight
Aug-24-15 Initiated Stifel Buy
View All

Vtv Therapeutics Inc Stock (VTVT) Latest News

pulisher
Oct 26, 2024

vTv Therapeutics Faces License Agreement Termination - Yahoo Finance

Oct 26, 2024
pulisher
Oct 26, 2024

How the (VTVT) price action is used to our Advantage - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 25, 2024

VTv, OnKure Terminate Cellular Drug Licensing Agreement - MarketWatch

Oct 25, 2024
pulisher
Oct 25, 2024

vTv Therapeutics ends key license agreement with OnKure - Investing.com

Oct 25, 2024
pulisher
Oct 25, 2024

VTv Therapeutics : Termination of Material Agreement Form 8 K - Marketscreener.com

Oct 25, 2024
pulisher
Oct 21, 2024

VTv Therapeutics: Q2 Earnings Snapshot - Barchart

Oct 21, 2024
pulisher
Oct 21, 2024

Alzheimer's disease Market Size in the 7MM was ~USD 3,500 Million in 2022 | DelveInsight - openPR

Oct 21, 2024
pulisher
Oct 15, 2024

Trading (VTVT) With Integrated Risk Controls - Stock Traders Daily

Oct 15, 2024
pulisher
Oct 04, 2024

Objective long/short (VTVT) Report - Stock Traders Daily

Oct 04, 2024
pulisher
Oct 03, 2024

Alzheimer’s disease Treatment Market Size in the 7MM was ~USD 3,500 Million in 2022, estimated DelveInsight - Barchart

Oct 03, 2024
pulisher
Sep 27, 2024

vTv Therapeutics (NASDAQ:VTVT) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024
pulisher
Sep 18, 2024

Views of Wall Street’s Leading Experts on Volcon Inc - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Travere Therapeutics Inc (TVTX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Valvoline Inc [VVV] Insider Activity: An Update for Investors - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Ventyx Biosciences Inc (VTYX) looking to reclaim success with recent performance - SETE News

Sep 18, 2024
pulisher
Sep 17, 2024

What is going on with VCHA? Cancellations, member hiatus and more - MSN

Sep 17, 2024
pulisher
Sep 17, 2024

Vital Energy Inc. (VTLE)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

Vanguard Total Corporate Bond Fund (NASDAQ:VTC) Reaches New 52-Week High at $79.92 - MarketBeat

Sep 17, 2024
pulisher
Sep 17, 2024

VTYX overperforms with a 2.18 increase in share price - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

VTLE’s latest rating updates from top analysts. - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

TV’s 2023 Market Dance: Down -32.71% – Time to Invest? - The InvestChronicle

Sep 17, 2024
pulisher
Sep 15, 2024

Texas Permanent School Fund Corp Sells 9,072 Shares of Veralto Co. (NYSE:VLTO) - Defense World

Sep 15, 2024
pulisher
Sep 13, 2024

Learn to Evaluate (VTVT) using the Charts - Stock Traders Daily

Sep 13, 2024
pulisher
Sep 13, 2024

Travere Therapeutics Inc [TVTX] Shares Rise 2.94 % on Thursday - Knox Daily

Sep 13, 2024
pulisher
Sep 12, 2024

Neighbors concerned with proposed hospital in Webster Groves - KTVI Fox 2 St. Louis

Sep 12, 2024
pulisher
Aug 28, 2024

When (VTVT) Moves Investors should Listen - Stock Traders Daily

Aug 28, 2024
pulisher
Aug 24, 2024

Here's Why We're Watching vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Situation - Simply Wall St

Aug 24, 2024
pulisher
Aug 16, 2024

We're Keeping An Eye On vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Rate - Yahoo Finance

Aug 16, 2024
pulisher
Aug 16, 2024

Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Rises By 45.9% - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

VTVT (vTv Therapeutics) Operating Cash Flow per Share : $-6.50 (TTM As of Jun. 2024) - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

VTVT (vTv Therapeutics) Free Cash Flow : $-21.81 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

VTVT (vTv Therapeutics) Change In Receivables : $-0.20 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

VTVT (vTv Therapeutics) Cyclically Adjusted Book per Share : $-228.01 (As of Jun. 2024) - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

VTVT (vTv Therapeutics) Short-Term Capital Lease Obligation : $0.18 Mil (As of Jun. 2024) - GuruFocus.com

Aug 16, 2024
pulisher
Aug 15, 2024

VTVT (vTv Therapeutics) Revenue per Share : $0.24 (TTM As of Jun. 2024) - GuruFocus.com

Aug 15, 2024
pulisher
Aug 15, 2024

VTVT (vTv Therapeutics) Ending Cash Position : $45.53 Mil (As of Jun. 2024) - GuruFocus.com

Aug 15, 2024
pulisher
Aug 15, 2024

VTVT (vTv Therapeutics) Net Income From Continuing Operatio - GuruFocus.com

Aug 15, 2024
pulisher
Aug 15, 2024

VTVT (vTv Therapeutics) Cash from Discontinued Operating Ac - GuruFocus.com

Aug 15, 2024
pulisher
Aug 15, 2024

VTVT (vTv Therapeutics) GF Value Rank : 1 (As of Aug. 15, 2024) - GuruFocus.com

Aug 15, 2024
pulisher
Aug 15, 2024

VTVT (vTv Therapeutics) Capex-to-Operating-Cash-Flow : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 15, 2024
pulisher
Aug 15, 2024

VTVT (vTv Therapeutics) Liabilities-to-Assets : 0.56 (As of Jun. 2024) - GuruFocus.com

Aug 15, 2024
pulisher
Aug 08, 2024

vTv Therapeutics Announces 2024 Second Quarter Financial Results and Provides Corporate Update - GlobeNewswire

Aug 08, 2024
pulisher
Aug 05, 2024

Where are the Opportunities in (VTVT) - Stock Traders Daily

Aug 05, 2024
pulisher
Jul 29, 2024

FDA puts High Point company's type-1 diabetes clinical trial on hold - Winston-Salem Journal

Jul 29, 2024
pulisher
Jul 29, 2024

Dow Edges Lower; Ventyx Biosciences Shares Plummet - Benzinga

Jul 29, 2024
pulisher
Jul 29, 2024

FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks - AOL

Jul 29, 2024
pulisher
Jul 29, 2024

Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump - Benzinga

Jul 29, 2024
pulisher
Jul 29, 2024

Nasdaq Gains 1%; McDonald's Posts Downbeat Results - Benzinga

Jul 29, 2024
pulisher
Jul 29, 2024

Why Is vTv Therapeutics (VTVT) Stock Down 46% Today? - InvestorPlace

Jul 29, 2024
pulisher
Jul 29, 2024

FDA places vTv Therapeutics’s cadisegliatin programme on clinical hold - Yahoo Finance

Jul 29, 2024
pulisher
Jul 29, 2024

Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga

Jul 29, 2024

Vtv Therapeutics Inc Stock (VTVT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.30
price up icon 1.75%
$75.59
price down icon 0.20%
$374.10
price down icon 0.29%
$52.67
price down icon 0.85%
$207.67
price up icon 0.20%
$108.59
price up icon 0.02%
Cap:     |  Volume (24h):